Tapewire

Nasdaq · USD

XENE

Xenon Pharmaceuticals Inc.

Export transactions ↓
Tapewire entity
2602
SEC CIK
0001582313
Parsed reports
275

Last 12 months

Inside the activity.

2 purchase rows · 26 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202503
Jan 202602
Feb 202600
Mar 2026015
Apr 202600
May 202600
Jun 202602
Jul 202600
Aug 202603
Sep 202620
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 04, 2022 Filed Mar 9, 2022 00:35 UTC
ROBIN SHERRINGTONEVP, Strategy & Innovation
Exercise / conversionStock Option (Right to Buy) · Derivative 1,234 $0.00 Strike: $3.67 $0.00
Disclosure

SEC source: 0001209191-22-017318 · doc4.xml · derivative · entry 8

ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 1,234 shares

Expires 2022-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise.

F6 · derivative.exercise_date: 1/3 of the shares subject to the Option vested on January 1, 2012 (the "First 2012 Vesting Commencement Date") and thereafter the remaining 2/3 of the shares subject to the Option vest each monthly anniversary of the First 2012 Vesting Commencement Date over the following 4 years.

F7 · derivative.expiration_date: Expiration date differs from originally reported date due to an automatic extension provided by the option plan as a result of the original expiration date falling during a Company blackout period.

Read SEC document
March 04, 2022 Filed Mar 9, 2022 00:35 UTC
ROBIN SHERRINGTONEVP, Strategy & Innovation
SaleCommon Shares 5,000 $30.23 $151,150.00
Disclosure

SEC source: 0001209191-22-017318 · doc4.xml · nonDerivative · entry 7

ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,232

F5 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.15 to $30.33, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
March 04, 2022 Filed Mar 9, 2022 00:35 UTC
ROBIN SHERRINGTONEVP, Strategy & Innovation
SaleCommon Shares 5,000 $31.05 $155,250.00
Disclosure

SEC source: 0001209191-22-017318 · doc4.xml · nonDerivative · entry 6

ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,232

F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.78 to $31.07, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
March 04, 2022 Filed Mar 9, 2022 00:35 UTC
ROBIN SHERRINGTONEVP, Strategy & Innovation
SaleCommon Shares 5,000 $30.15 $150,750.00
Disclosure

SEC source: 0001209191-22-017318 · doc4.xml · nonDerivative · entry 5

ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,232

F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.10 to $31.17, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
March 04, 2022 Filed Mar 9, 2022 00:35 UTC
ROBIN SHERRINGTONEVP, Strategy & Innovation
SaleCommon Shares 6,710 $30.56 $205,057.60
Disclosure

SEC source: 0001209191-22-017318 · doc4.xml · nonDerivative · entry 4

ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,232

F2 · price: Represents the closing price of the Company's common shares on March 3, 2022, which was converted to a Canadian dollar amount for purposes of net settlement calculations.

Read SEC document
March 04, 2022 Filed Mar 9, 2022 00:35 UTC
ROBIN SHERRINGTONEVP, Strategy & Innovation
Exercise / conversionCommon Shares 6,172 $3.67 $22,651.24
Disclosure

SEC source: 0001209191-22-017318 · doc4.xml · nonDerivative · entry 3

ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,942

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise.

Read SEC document
March 04, 2022 Filed Mar 9, 2022 00:35 UTC
ROBIN SHERRINGTONEVP, Strategy & Innovation
Tax withholdingCommon Shares 696 $31.42 $21,868.32
Disclosure

SEC source: 0001209191-22-017318 · doc4.xml · nonDerivative · entry 2

ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,770

F2 · price: Represents the closing price of the Company's common shares on March 3, 2022, which was converted to a Canadian dollar amount for purposes of net settlement calculations.

Read SEC document
March 04, 2022 Filed Mar 9, 2022 00:35 UTC
ROBIN SHERRINGTONEVP, Strategy & Innovation
Exercise / conversionCommon Shares 1,234 $3.67 $4,528.78
Disclosure

SEC source: 0001209191-22-017318 · doc4.xml · nonDerivative · entry 1

ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,466

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise.

Read SEC document
January 21, 2022 Filed Jan 21, 2022 22:04 UTC
KENNEY CHRISTOPHER JOHNChief Medical Officer
PurchaseCommon Shares 700 $28.81 $20,167.00
Disclosure

SEC source: 0001209191-22-004460 · doc4.xml · nonDerivative · entry 1

KENNEY CHRISTOPHER JOHN · CIK 0001880129 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 700

Read SEC document
December 15, 2021 Filed Dec 17, 2021 16:04 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 3,086 $0.00 Strike: $3.67 $0.00
Disclosure

SEC source: 0001209191-21-070231 · doc4.xml · derivative · entry 2

AZAB MOHAMMAD · CIK 0001309653 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 3,086 shares

Expires 2021-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

F2 · derivative.exercise_date: 1/3 of the shares subject to the Option vested on January 1, 2013 (the "2012 Vesting Commencement Date") and thereafter the remaining 2/3 of the shares subject to the Option vest each monthly anniversary of the 2012 Vesting Commencement Date over the following 2 years.

Read SEC document
December 15, 2021 Filed Dec 17, 2021 16:04 UTC Exercise / conversionCommon Shares 3,086 $3.67 $11,325.62
Disclosure

SEC source: 0001209191-21-070231 · doc4.xml · nonDerivative · entry 1

AZAB MOHAMMAD · CIK 0001309653 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,819

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

Read SEC document
December 08, 2021 Filed Dec 10, 2021 21:20 UTC
PATOU GARYDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 2,057 $0.00 Strike: $3.67 $0.00
Disclosure

SEC source: 0001209191-21-069018 · doc4.xml · derivative · entry 3

PATOU GARY · CIK 0001283535 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 2,057 shares

Expires 2021-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

F3 · derivative.exercise_date: 1/3 of the shares subject to the Option vested on January 1, 2013 (the "2012 Vesting Commencement Date") and thereafter the remaining 2/3 of the shares subject to the Option vest each monthly anniversary of the 2012 Vesting Commencement Date over the following 2 years.

Read SEC document
December 08, 2021 Filed Dec 10, 2021 21:20 UTC
PATOU GARYDirector
Exercise / conversionCommon Shares 2,057 $3.67 $7,549.19
Disclosure

SEC source: 0001209191-21-069018 · doc4.xml · nonDerivative · entry 1

PATOU GARY · CIK 0001283535 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,630

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

Read SEC document
December 06, 2021 Filed Dec 7, 2021 21:13 UTC
Von Seggern ChristopherChief Commercial Officer
PurchaseCommon Shares 4,000 $24.40 $97,600.00
Disclosure

SEC source: 0001209191-21-068300 · doc4.xml · nonDerivative · entry 1

Von Seggern Christopher · CIK 0001821192 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,000

Read SEC document
November 15, 2021 Filed Nov 16, 2021 20:40 UTC SaleCommon Shares 17,557 $31.33 $550,060.81
Disclosure

SEC source: 0001209191-21-064931 · doc4.xml · nonDerivative · entry 1

PIMSTONE SIMON N. · CIK 0001620084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 210,186

F1 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $31.10 to $31.85, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein

Read SEC document
August 23, 2021 Filed Aug 25, 2021 20:12 UTC
KENNEY CHRISTOPHER JOHNChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 150,000 $0.00 Strike: $16.64 $0.00
Disclosure

SEC source: 0001209191-21-053304 · doc4.xml · derivative · entry 1

KENNEY CHRISTOPHER JOHN · CIK 0001880129 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Shares · 150,000 shares

Expires 2031-08-22

F1 · derivative.exercise_date: Vesting 25% on the one year anniversary of the grant date, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.

Read SEC document
June 03, 2021 Filed Jun 3, 2021 16:42 UTC
AULIN SHERRYChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $18.56 $0.00
Disclosure

SEC source: 0001209191-21-037692 · doc4.xml · derivative · entry 1

AULIN SHERRY · CIK 0001862144 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Shares · 100,000 shares

Expires 2031-06-02

F1 · derivative.exercise_date: Vesting 25% on the one year anniversary of the grant date, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.

Read SEC document
June 03, 2021 Filed Jun 4, 2021 01:04 UTC GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $18.56 $0.00
Disclosure

SEC source: 0001209191-21-038063 · doc4.xml · derivative · entry 1

GANNON STEVEN · CIK 0001643085 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Shares · 10,000 shares

Expires 2031-06-02

F1 · derivative.exercise_date: One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date.

Read SEC document
June 03, 2021 Filed Jun 4, 2021 01:07 UTC GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $18.56 $0.00
Disclosure

SEC source: 0001209191-21-038067 · doc4.xml · derivative · entry 1

Hayden Michael R · CIK 0001352908 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Shares · 10,000 shares

Expires 2031-06-02

F1 · derivative.exercise_date: One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date.

Read SEC document
June 03, 2021 Filed Jun 3, 2021 21:02 UTC GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $18.56 $0.00
Disclosure

SEC source: 0001209191-21-038058 · doc4.xml · derivative · entry 1

AZAB MOHAMMAD · CIK 0001309653 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Shares · 10,000 shares

Expires 2031-06-02

F1 · derivative.exercise_date: One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date.

Read SEC document
June 03, 2021 Filed Jun 4, 2021 01:09 UTC GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $18.56 $0.00
Disclosure

SEC source: 0001209191-21-038070 · doc4.xml · derivative · entry 1

Machado Patrick · CIK 0001311210 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Shares · 10,000 shares

Expires 2031-06-02

F1 · derivative.exercise_date: One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date.

Read SEC document
June 03, 2021 Filed Jun 4, 2021 01:16 UTC GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $18.56 $0.00
Disclosure

SEC source: 0001209191-21-038079 · doc4.xml · derivative · entry 1

Svoronos Dawn · CIK 0001574579 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Shares · 10,000 shares

Expires 2031-06-02

F1 · derivative.exercise_date: One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date.

Read SEC document
June 03, 2021 Filed Jun 4, 2021 01:00 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $18.56 $0.00
Disclosure

SEC source: 0001209191-21-038055 · doc4.xml · derivative · entry 1

GAROFALO ELIZABETH A. · CIK 0001826361 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Shares · 20,000 shares

Expires 2031-06-02

F1 · derivative.exercise_date: One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date.

Read SEC document
June 03, 2021 Filed Jun 3, 2021 20:46 UTC
MORTIMER IANDirector · PRESIDENT & CEO
GrantStock Option (Right to Buy) · Derivative 125,000 $0.00 Strike: $18.56 $0.00
Disclosure

SEC source: 0001209191-21-037707 · doc4.xml · derivative · entry 1

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Shares · 125,000 shares

Expires 2031-06-02

F1 · derivative.exercise_date: 25% on the first anniversary of June 3, 2021 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.

Read SEC document
June 03, 2021 Filed Jun 4, 2021 23:20 UTC
PATOU GARYDirector
GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $18.56 $0.00
Disclosure

SEC source: 0001209191-21-038431 · doc4.xml · derivative · entry 4

PATOU GARY · CIK 0001283535 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Shares · 10,000 shares

Expires 2031-06-02

F3 · derivative.exercise_date: One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date.

Read SEC document
May 28, 2021 Filed Jun 1, 2021 20:11 UTC
ROBIN SHERRINGTONEVP, Strategy & Innovation
Exercise / conversionStock Option (Right to Buy) · Derivative 13,374 $0.00 Strike: $3.85 $0.00
Disclosure

SEC source: 0001209191-21-036802 · doc4.xml · derivative · entry 8

ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 13,374 shares

Expires 2021-05-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

F6 · derivative.exercise_date: 1/3 of the shares subject to the Option vested on March 12, 2011 (the "March 2011 Vesting Commencement Date") and thereafter the remaining 2/3 of the shares subject to the Option vest each monthly anniversary of the March 2011 Vesting Commencement Date over the following 4 years.

F5 · derivative.expiration_date: Expiration date differs from originally reported date due to an automatic extension provided by the option plan as a result of the original expiration date falling during a Company blackout period and a lock-up agreement period.

Read SEC document
May 28, 2021 Filed Jun 1, 2021 20:11 UTC
ROBIN SHERRINGTONEVP, Strategy & Innovation
Exercise / conversionStock Option (Right to Buy) · Derivative 12,345 $0.00 Strike: $3.76 $0.00
Disclosure

SEC source: 0001209191-21-036802 · doc4.xml · derivative · entry 7

ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 12,345 shares

Expires 2021-05-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

F4 · derivative.exercise_date: 25% of the shares subject to the Option vested on the one year anniversary of January 1, 2011 (the "January 2011 Vesting Commencement Date") and thereafter 1/48th of the shares subject to the Option vest on each monthly anniversary of the January 2011 Vesting Commencement Date.

F5 · derivative.expiration_date: Expiration date differs from originally reported date due to an automatic extension provided by the option plan as a result of the original expiration date falling during a Company blackout period and a lock-up agreement period.

Read SEC document
May 28, 2021 Filed Jun 1, 2021 20:11 UTC
ROBIN SHERRINGTONEVP, Strategy & Innovation
SaleCommon Shares 2,912 $18.81 $54,774.72
Disclosure

SEC source: 0001209191-21-036802 · doc4.xml · nonDerivative · entry 6

ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,232

F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $18.22 to $19.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein

Read SEC document
May 28, 2021 Filed Jun 1, 2021 20:11 UTC
ROBIN SHERRINGTONEVP, Strategy & Innovation
SaleCommon Shares 3,155 $18.81 $59,345.55
Disclosure

SEC source: 0001209191-21-036802 · doc4.xml · nonDerivative · entry 5

ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,144

F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $18.22 to $19.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein

Read SEC document
May 28, 2021 Filed Jun 1, 2021 20:11 UTC
ROBIN SHERRINGTONEVP, Strategy & Innovation
Tax withholdingCommon Shares 2,192 $18.91 $41,450.72
Disclosure

SEC source: 0001209191-21-036802 · doc4.xml · nonDerivative · entry 4

ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,299

F2 · price: Represents the closing price of the Company's common shares on May 27, 2021, which was converted to a Canadian dollar amount for purposes of net settlement calculations.

Read SEC document
May 28, 2021 Filed Jun 1, 2021 20:11 UTC
ROBIN SHERRINGTONEVP, Strategy & Innovation
Exercise / conversionCommon Shares 13,374 $3.85 $51,489.90
Disclosure

SEC source: 0001209191-21-036802 · doc4.xml · nonDerivative · entry 3

ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,491

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

Read SEC document
May 28, 2021 Filed Jun 1, 2021 20:11 UTC
ROBIN SHERRINGTONEVP, Strategy & Innovation
Tax withholdingCommon Shares 2,024 $18.91 $38,273.84
Disclosure

SEC source: 0001209191-21-036802 · doc4.xml · nonDerivative · entry 2

ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,117

F2 · price: Represents the closing price of the Company's common shares on May 27, 2021, which was converted to a Canadian dollar amount for purposes of net settlement calculations.

Read SEC document
May 28, 2021 Filed Jun 1, 2021 20:11 UTC
ROBIN SHERRINGTONEVP, Strategy & Innovation
Exercise / conversionCommon Shares 12,345 $3.76 $46,417.20
Disclosure

SEC source: 0001209191-21-036802 · doc4.xml · nonDerivative · entry 1

ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,141

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 16:07 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 36,008 $0.00 Strike: $3.76 $0.00
Disclosure

SEC source: 0001209191-21-036798 · doc4.xml · derivative · entry 9

HOLLER FRANK A · CIK 0000938801 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 36,008 shares

Expires 2021-05-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

F5 · derivative.exercise_date: The shares subject to the option fully vested on December 31, 2013. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3.

F6 · derivative.expiration_date: Expiration date differs from originally reported date due to an automatic extension provided by the option plan as a result of the original expiration date falling during a Company blackout period and a lock-up agreement period.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 16:07 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 3,086 $0.00 Strike: $3.76 $0.00
Disclosure

SEC source: 0001209191-21-036798 · doc4.xml · derivative · entry 8

HOLLER FRANK A · CIK 0000938801 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 3,086 shares

Expires 2021-05-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

F5 · derivative.exercise_date: The shares subject to the option fully vested on December 31, 2013. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3.

F6 · derivative.expiration_date: Expiration date differs from originally reported date due to an automatic extension provided by the option plan as a result of the original expiration date falling during a Company blackout period and a lock-up agreement period.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 16:07 UTC SaleCommon Shares 8,485 $18.68 $158,499.80
Disclosure

SEC source: 0001209191-21-036798 · doc4.xml · nonDerivative · entry 6

HOLLER FRANK A · CIK 0000938801 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,653

F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $18.54 to $18.92, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein

Read SEC document
May 27, 2021 Filed Jun 1, 2021 16:07 UTC SaleCommon Shares 2,579 $18.69 $48,201.51
Disclosure

SEC source: 0001209191-21-036798 · doc4.xml · nonDerivative · entry 5

HOLLER FRANK A · CIK 0000938801 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,138

F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $18.51 to $18.92, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein

Read SEC document
May 27, 2021 Filed Jun 1, 2021 16:07 UTC Tax withholdingCommon Shares 5,911 $18.88 $111,599.68
Disclosure

SEC source: 0001209191-21-036798 · doc4.xml · nonDerivative · entry 4

HOLLER FRANK A · CIK 0000938801 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,717

F2 · price: Represents the closing price of the Company's common shares on May 26, 2021, which was converted to a Canadian dollar amount for purposes of net settlement calculations.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 16:07 UTC Exercise / conversionCommon Shares 36,008 $3.76 $135,390.08
Disclosure

SEC source: 0001209191-21-036798 · doc4.xml · nonDerivative · entry 3

HOLLER FRANK A · CIK 0000938801 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,628

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 16:07 UTC Tax withholdingCommon Shares 507 $18.88 $9,572.16
Disclosure

SEC source: 0001209191-21-036798 · doc4.xml · nonDerivative · entry 2

HOLLER FRANK A · CIK 0000938801 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,620

F2 · price: Represents the closing price of the Company's common shares on May 26, 2021, which was converted to a Canadian dollar amount for purposes of net settlement calculations.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 16:07 UTC Exercise / conversionCommon Shares 3,086 $3.76 $11,603.36
Disclosure

SEC source: 0001209191-21-036798 · doc4.xml · nonDerivative · entry 1

HOLLER FRANK A · CIK 0000938801 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,127

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

Read SEC document
May 24, 2021 Filed May 26, 2021 16:11 UTC
PIMSTONE SIMON N.Director · CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 22,633 $0.00 Strike: $3.76 $0.00
Disclosure

SEC source: 0001209191-21-035911 · doc4.xml · derivative · entry 3

PIMSTONE SIMON N. · CIK 0001620084 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 22,633 shares

Expires 2021-05-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

F3 · derivative.exercise_date: 25% of the shares subject to the Option vested on the one year anniversary of January 1, 2011 (the "2011 Vesting Commencement Date") and thereafter 1/48th of the shares subject to the Option vest on each monthly anniversary of the 2011 Vesting Commencement Date.

F4 · derivative.expiration_date: Expiration date differs from originally reported date due to an automatic extension provided by the option plan as a result of the original expiration date falling during a Company blackout period and a lock-up agreement period.

Read SEC document
May 24, 2021 Filed May 26, 2021 16:11 UTC
PIMSTONE SIMON N.Director · CEO
Tax withholdingCommon Shares 5,076 $19.17 $97,306.92
Disclosure

SEC source: 0001209191-21-035911 · doc4.xml · nonDerivative · entry 2

PIMSTONE SIMON N. · CIK 0001620084 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 227,743

F2 · price: Represents the closing price of the Company's common shares on May 21, 2021, which was converted to a Canadian dollar amount for purposes of net settlement calculations.

Read SEC document
May 24, 2021 Filed May 26, 2021 16:11 UTC
PIMSTONE SIMON N.Director · CEO
Exercise / conversionCommon Shares 22,633 $3.76 $85,100.08
Disclosure

SEC source: 0001209191-21-035911 · doc4.xml · nonDerivative · entry 1

PIMSTONE SIMON N. · CIK 0001620084 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 232,819

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

Read SEC document
May 18, 2021 Filed May 20, 2021 20:13 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 3,500 $0.00 Strike: $3.85 $0.00
Disclosure

SEC source: 0001209191-21-034396 · doc4.xml · derivative · entry 4

Hayden Michael R · CIK 0001352908 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 3,500 shares

Expires 2027-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, and the balance of the total shares subject to the Option shall vest on the three year anniversary of the grant date. The original grant date of the option is June 1, 2017.

Read SEC document
May 18, 2021 Filed May 20, 2021 20:13 UTC Exercise / conversionCommon Shares 3,500 $3.85 $13,475.00
Disclosure

SEC source: 0001209191-21-034396 · doc4.xml · nonDerivative · entry 1

Hayden Michael R · CIK 0001352908 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,206

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: No shares were sold by the Reporting Person in connection with the exercise and the common shares issued as a result of the exercise are subject to the terms of a lock-up agreement executed by the Reporting Person in favor of the underwriters of the Company's public offering in March 2021.

Read SEC document
May 18, 2021 Filed May 20, 2021 16:18 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,144 $0.00 Strike: $3.67 $0.00
Disclosure

SEC source: 0001209191-21-034400 · doc4.xml · derivative · entry 6

TARNOW MICHAEL M · CIK 0001263647 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 5,144 shares

Expires 2021-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

F4 · derivative.exercise_date: 1/3 of the shares subject to the Option vested on January 1, 2013 (the "First 2012 Vesting Commencement Date") and thereafter the remaining 2/3 of the shares subject to the Option vest each monthly anniversary of the First 2012 Vesting Commencement Date over the following 2 years.

Read SEC document
May 18, 2021 Filed May 20, 2021 16:18 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 1,028 $0.00 Strike: $3.67 $0.00
Disclosure

SEC source: 0001209191-21-034400 · doc4.xml · derivative · entry 5

TARNOW MICHAEL M · CIK 0001263647 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 1,028 shares

Expires 2021-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

F4 · derivative.exercise_date: 1/3 of the shares subject to the Option vested on January 1, 2013 (the "First 2012 Vesting Commencement Date") and thereafter the remaining 2/3 of the shares subject to the Option vest each monthly anniversary of the First 2012 Vesting Commencement Date over the following 2 years.

Read SEC document
May 18, 2021 Filed May 20, 2021 16:18 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 2,057 $0.00 Strike: $3.87 $0.00
Disclosure

SEC source: 0001209191-21-034400 · doc4.xml · derivative · entry 4

TARNOW MICHAEL M · CIK 0001263647 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 2,057 shares

Expires 2021-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

F3 · derivative.exercise_date: The shares subject to the option fully vested on July 1, 2014.

Read SEC document
May 18, 2021 Filed May 20, 2021 16:18 UTC Exercise / conversionCommon Shares 5,144 $3.67 $18,878.48
Disclosure

SEC source: 0001209191-21-034400 · doc4.xml · nonDerivative · entry 3

TARNOW MICHAEL M · CIK 0001263647 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,942

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: No shares were sold by the Reporting Person in connection with the exercise and the common shares issued as a result of the exercise are subject to the terms of a lock-up agreement executed by the Reporting Person in favor of the underwriters of the Company's public offering in March 2021.

F2 · price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.